MX2008016558A - Preparacion y aplicacion terapéutica de derivados de 2-benzoil-imidazopiridinas. - Google Patents

Preparacion y aplicacion terapéutica de derivados de 2-benzoil-imidazopiridinas.

Info

Publication number
MX2008016558A
MX2008016558A MX2008016558A MX2008016558A MX2008016558A MX 2008016558 A MX2008016558 A MX 2008016558A MX 2008016558 A MX2008016558 A MX 2008016558A MX 2008016558 A MX2008016558 A MX 2008016558A MX 2008016558 A MX2008016558 A MX 2008016558A
Authority
MX
Mexico
Prior art keywords
group
optionally substituted
cycloalkyl
sub
derivatives
Prior art date
Application number
MX2008016558A
Other languages
English (en)
Inventor
Youssef El-Ahmad
Jean-Francois Peyronel
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MX2008016558A publication Critical patent/MX2008016558A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a derivados que tienen la fórmula general (I), en donde X representa un grupo fenilo opcionalmente sustituido; R1 representa un átomo de hidrógeno, un grupo alcoxi (de 1 a 6 átomos de carbono) opcionalmente sustituido, un grupo alquilo (de 1 a 6 átomos de carbono), un grupo cicloalquil(de 3 a 7 átomos de carbono)-alquilo(de 1 a 6 átomos de carbono), un grupo cicloalquil(de 3 a 7 átomos de carbono)-alcoxi(de 1 a 6 átomos de carbono), un hidroxi, un amino; R2 representa un átomo de hidrógeno, un grupo alquilo (de 1 a 6 átomos de carbono) opcionalmente sustituido, un grupo alcoxi (de 1 a 6 átomos de carbono) opcionalmente sustituido, un grupo cicloalquil(de 3 a 7 átomos de carbono)-alquilo(de 1 a 6 átomos de carbono), un grupo cicloalquil(de 3 a 7 átomos de carbono)-alcoxi(de 1 a 6 átomos de carbono), un grupo alquileno (de 2 a 6 átomos de carbono), un grupo alquinilo (de 2 a 6 átomos de carbono), un grupo -CO-R5-, un grupo -CO-NR6R7, -CO-O-R8-, un grupo -NR9-CO-R10, un grupo -NR11, R12, un átomo de halógeno, un grupo ciano o un grupo fenilo opcionalmente sustituido; R3 representa un átomo de hidrógeno, un grupo alquilo (de 1 a 6 átomos de carbono) o un átomo de halógeno; y R4 representa un átomo de hidrógeno o un átomo de halógeno, los derivados toman la forma de una base o una sal de adición de ácido. La invención también se refiere a su método de preparación y su uso en terapéutica.
MX2008016558A 2006-07-03 2007-07-03 Preparacion y aplicacion terapéutica de derivados de 2-benzoil-imidazopiridinas. MX2008016558A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0606010A FR2903105A1 (fr) 2006-07-03 2006-07-03 Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique
PCT/FR2007/001123 WO2008003854A2 (fr) 2006-07-03 2007-07-03 Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
MX2008016558A true MX2008016558A (es) 2009-05-20

Family

ID=37661856

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008016558A MX2008016558A (es) 2006-07-03 2007-07-03 Preparacion y aplicacion terapéutica de derivados de 2-benzoil-imidazopiridinas.

Country Status (21)

Country Link
US (1) US7902219B2 (es)
EP (1) EP2040703B1 (es)
JP (1) JP2009541469A (es)
KR (1) KR20090024775A (es)
CN (1) CN101484163A (es)
AT (1) ATE446089T1 (es)
AU (1) AU2007271082A1 (es)
BR (1) BRPI0713260A2 (es)
CA (1) CA2656045A1 (es)
CY (1) CY1109743T1 (es)
DE (1) DE602007002915D1 (es)
DK (1) DK2040703T3 (es)
ES (1) ES2335323T3 (es)
FR (1) FR2903105A1 (es)
IL (1) IL195818A0 (es)
MX (1) MX2008016558A (es)
PL (1) PL2040703T3 (es)
PT (1) PT2040703E (es)
RU (1) RU2009103300A (es)
SI (1) SI2040703T1 (es)
WO (1) WO2008003854A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925907B1 (fr) * 2008-01-02 2010-10-15 Sanofi Aventis DERIVES DE 2-HETEROAROYL-IMIDAZO°1,2-a!PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2925905B1 (fr) * 2008-01-02 2010-11-05 Sanofi Aventis DERIVES DE 2-BENZOYL-IMIDAZO°1,2-a!PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2928921B1 (fr) * 2008-03-21 2010-04-23 Sanofi Aventis Derives polysubstitues de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines, leur preparation et leur application en therapeutique
FR2928922B1 (fr) * 2008-03-21 2010-04-23 Sanofi Aventis Derives de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines polysubstitues, leur preparation et leur application en therapeutique
FR2928923B1 (fr) * 2008-03-21 2010-04-23 Sanofi Aventis Derives polysubstitues de 2-heteroaryl-6-phenyl-imidazo °1,2-a!pyridines, leur preparation et leur application en therapeutiques
FR2928924B1 (fr) * 2008-03-21 2010-04-23 Sanofi Aventis Derives polysubstitues de 6-heteroaryle-imidazo°1,2-a! pyridines, leur preparation et leur application en therapeutique
FR2933609B1 (fr) 2008-07-10 2010-08-27 Fournier Lab Sa Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson.
FR2950053B1 (fr) 2009-09-11 2014-08-01 Fournier Lab Sa Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
FR2955110A1 (fr) 2010-01-08 2011-07-15 Fournier Lab Sa Nouveaux derives de type pyrrolopyridine benzoique
CN103772381B (zh) * 2013-09-16 2015-11-25 广东华南新药创制中心 一种四稠环喹啉类化合物及其制备方法
WO2021204626A1 (en) 2020-04-06 2021-10-14 Almirall, S.A. Aryl and heteroaryl-carboxamide substituted heteroaryl compounds as tyk2 inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2638161B1 (fr) * 1988-10-24 1991-01-11 Centre Nat Rech Scient Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
US6489337B1 (en) * 2000-03-31 2002-12-03 Ortho-Mcneil Pharmaceutical, Inc. Method for treating histamine H3 receptor-mediated disorders with 2- or 3-aryl substituted imidazo[1,2-a] pyridines
DE10117184A1 (de) 2001-04-05 2002-10-17 Gruenenthal Gmbh Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen
JP5082033B2 (ja) * 2001-12-21 2012-11-28 エグゼリクシス パテント カンパニー エルエルシー Ｌｘｒのモジュレーター
GB0303503D0 (en) 2003-02-14 2003-03-19 Novartis Ag Organic compounds
WO2004089366A1 (en) * 2003-04-10 2004-10-21 Pfizer Japan, Inc. Bicyclic compounds as nr2b receptor antagonists
AR045944A1 (es) 2003-09-24 2005-11-16 Novartis Ag Derivados de isoquinolina 1.4-disustituidas
JP4842829B2 (ja) * 2003-10-31 2011-12-21 武田薬品工業株式会社 含窒素縮合複素環化合物
WO2005048953A2 (en) 2003-11-13 2005-06-02 Ambit Biosciences Corporation Amide derivatives as kinase modulators
WO2006024834A1 (en) 2004-08-31 2006-03-09 Astrazeneca Ab Quinazolinone derivatives and their use as b-raf inhibitors
AR053992A1 (es) 2004-12-22 2007-05-30 Astrazeneca Ab Compuestos quimicos con actividad anticancerosa, un procedimiento para su preparacion, su uso en la preparacion de medicamentos y composicion farmaceutica.
DE602005013819D1 (de) 2004-12-22 2009-05-20 Astrazeneca Ab Pyridincarbonsäureamidderivate zur verwendung als antikrebsmittel

Also Published As

Publication number Publication date
US20090143420A1 (en) 2009-06-04
WO2008003854A3 (fr) 2008-03-06
CY1109743T1 (el) 2014-09-10
ES2335323T3 (es) 2010-03-24
CN101484163A (zh) 2009-07-15
DK2040703T3 (da) 2010-03-08
IL195818A0 (en) 2009-09-01
CA2656045A1 (fr) 2008-01-10
PL2040703T3 (pl) 2010-03-31
BRPI0713260A2 (pt) 2012-04-03
SI2040703T1 (sl) 2010-02-26
DE602007002915D1 (de) 2009-12-03
EP2040703B1 (fr) 2009-10-21
RU2009103300A (ru) 2010-08-10
KR20090024775A (ko) 2009-03-09
ATE446089T1 (de) 2009-11-15
EP2040703A2 (fr) 2009-04-01
FR2903105A1 (fr) 2008-01-04
PT2040703E (pt) 2010-01-19
WO2008003854A2 (fr) 2008-01-10
JP2009541469A (ja) 2009-11-26
AU2007271082A1 (en) 2008-01-10
US7902219B2 (en) 2011-03-08

Similar Documents

Publication Publication Date Title
MX2008016558A (es) Preparacion y aplicacion terapéutica de derivados de 2-benzoil-imidazopiridinas.
MX344669B (es) Agente antiplaquetas novedoso.
MX2009002802A (es) Derivados de 2-aril-6-fenil-imidazo[1,2-a]piridinas, su preparacion y su aplicacion en terapeutica.
TW200531683A (en) Aryl- and heteroarylpiperidinecarboxylate derivatives, their preparation and their application in therapeutics
SI2091948T1 (sl) Novi inhibitorji glutaminil ciklaze
MX2012004453A (es) Composicion para el control de plagas.
TW200621786A (en) Condensed pyrazole derivatives, their preparation and application in therapeutics
MY150289A (en) Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof
MX2010002904A (es) N-fenil-dioxo-hidropirimidinas utiles como inhibidores de virus de hepatitis c (hcv).
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
MX2009008779A (es) Composicion farmacéutica que comprende derivado de pirazina y método para usar el derivado de pirazina en combinación.
WO2009118473A3 (fr) Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
MX2009013515A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica.
TW200607808A (en) Pyrido-pyrimidine derivatives, preparation thereof and application thereof
SG155946A1 (en) Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
MX2012006805A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa.
TW200609223A (en) Process for the preparation of n-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
MX2010007351A (es) Derivados de imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su aplicacion en terapeutica.
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
TW200708506A (en) Derivatives of triazines, their preparation and their application in therapeutics
TNSN08161A1 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
TNSN07439A1 (en) Derivatives of,4,5 - diarylpyrrole, preparation method thereof and use of same in therapeutics
WO2008003855A3 (fr) Utilisation de 2-benzoyl-imidazopyridines en thérapeutique
MX2010007349A (es) Derivados de n-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas , su preparacion y su aplicacion terapeutica.